Research Report on Vaccines.edited.edited

docx

School

Nairobi Institute of Technology - Westlands *

*We aren’t endorsed by this school

Course

MISC

Subject

Biology

Date

Nov 24, 2024

Type

docx

Pages

Uploaded by dannetke

1 Research Report on Vaccines Name Institution Affiliation Instructor’s Name Course Date 1

2 Abstract Vaccines are crucial for public health protection because they prevent the spread of infectious diseases. This study examines the idea and importance of vaccinations, their history, and the first physician to test vaccines. It also covers many vaccination forms, such as mRNA, inactivated, live attenuated, subunit, recombinant, and vaccines made from recombinant proteins. The study underlines the value of vaccinations to achieve herd immunity, create immunological memory, and safeguard vulnerable people. It also draws attention to Edward Jenner's contributions, who popularized the word "vaccine" and established the principles behind current vaccination methods. Concept of Vaccines Biological preparations called vaccines encourage the immune system to identify and fight against certain infections. Vaccines hone the immune system's ability to mount a defense by delivering viruses or their antigens into the body in weakened or inactivated form. In the case of subsequent exposure, this immune response aids in the identification and eradication of the real pathogen, preventing infection and sickness (Dubé et al., 2021). Vaccines may include additives like adjuvants or immune-stimulating chemicals that improve the body's immunological response. These extra components aid in boosting the immune response and the vaccine's efficacy. Immunological memory is the foundation of the vaccination theory (Brisse et al., 2022). When it encounters a virus, the immune system reacts. The immune system "learns" to recognize the infection's antigens during this process. Antigens, molecules on infection surfaces, are foreign and targets for the immune system. Moreover, the immune system is exposed to harmless copies of infections or their antigens in vaccinations, which helps them take advantage of the immunological memory. 2

3 Inactivated (killed) pathogens, weaker (attenuated) forms of the pathogen, or particular components, such as proteins or carbohydrates, may all be considered harmless variants. When the immune system recognizes these antigens, it triggers an immunological response that includes antibody formation and immune cell activation (Dubé et al., 2021). The immunological response from vaccinations enables the body to "remember" the unique antigens connected to a certain infection. When the immune system confronts a real infection in the future, this memory enables the immune system to react quickly and efficiently (Brisse et al., 2022). When a person who has received vaccinations is exposed to the virus, their immune system will be able to swiftly identify it and build a powerful defense, avoiding or lessening the severity of the sickness. The idea of herd immunity is strengthened through vaccination, protecting those who get it. Herd immunity occurs when a sizable fraction of the population has developed immunity to a particular illness, either due to vaccination or prior exposure (Dubé et al., 2021). A community with enough immune individuals limits the pathogen's transmission, protecting others who cannot acquire the vaccination, such as those with impaired immune systems or medical issues (Dubé et al., 2021). immunizations must undergo rigorous testing and regulatory standards before approval to ensure safety and effectiveness. Vaccines are often tested in the lab and on animals before being tested on humans for safety and efficacy (Brisse et al., 2022). Before approving a product for use in the broader public, regulatory authorities carefully examine the data from these studies. Origin of the Name "Vaccine" The late 18th-century research of English physician Edward Jenner is when the word "vaccine" first appeared. According to Saleh et al. (2002), Jenner noticed that milkmaids who had cowpox, which resembles smallpox but has fewer symptoms, seemed resistant to smallpox. 3

Your preview ends here

Eager to read complete document? Join bartleby learn and gain access to the full version

Access to all documents
Unlimited textbook solutions
24/7 expert homework help

4 In 1796, Jenner conducted an experiment in which he injected an eight-year-old kid called James Phipps with fluid from cowpox blisters. Jenner subsequently gave Phipps smallpox, but the kid was immune. Jenner coined the phrase "vaccine"—derived from the Latin word "vacca," which means cow to characterize this cutting-edge preventative method. Additionally, Jenner's work served as the basis for creating vaccinations as we know them today. According to Iwasaki and Omer (2020), "vaccine" refers to a biological treatment that confers protection to certain illnesses. The creation of the smallpox vaccine was made possible by Jenner's discovery of the protective properties of cowpox (Esparza, 2020). The Latin term "Vacca," which means "cow," gave rise to the English word "vaccine," which came to be connected with this preventative measure. He gave it this name because cowpox was so important to Jenner's experiment. The field of vaccination has advanced greatly since Jenner's time (Saleh et al., 2021). Vaccines have been created for several diseases, offering protection against formerly fatal ailments. Nowadays, the word "vaccine" is generally used to refer to any method of preventing infection by infectious illnesses. First Doctor to Conduct Vaccine Experiments As was already noted, Edward Jenner is usually regarded as the first physician to test vaccines. Modern vaccination techniques were developed due to his ground-breaking work with cowpox (Esparza, 2020). Smallpox was successfully eradicated thanks to Jenner's pioneering work, which helped develop immunology science. Jenner also changed medicine. Late 18th century, smallpox killed many and caused widespread disease. Jenner noticed that milkmaids with cowpox, a far less severe illness, seemed resistant to smallpox. By taking fluid from a cowpox sore on milkmaid Sarah Nelmes, Jenner performed his first vaccination trial in 1796 (Saleh et al., 2021). Through a little cut on his arm, he then injected the fluid into a young kid 4

5 called James Phipps. Later, Phipps had a small case of cowpox and recovered. Phipps was subsequently introduced to smallpox by Jenner, but the kid showed immunity by not becoming ill. The idea of vaccination, derived from the Latin term "Vacca," which means cow, was founded on Jenner's discoveries. He named the operation "vaccine" to prevent a more dangerous illness (Esparza, 2020). Jenner's cowpox research led to the smallpox vaccine, which eliminated the disease by the late 20th century. His research advanced immunology and illness prevention. Jenner's study helped us understand the immune system and how to combat infectious diseases. Vaccination saves lives and is now a public health need. The creation of vaccinations against several illnesses and other developments in immunization was made possible by Jenner's vaccine studies, which were a great success (Esparza, 2020). His contributions to medicine and public health are well acknowledged and have an ongoing impact on medical procedures. Types of Vaccines Inactivated Vaccines: According to Gao et al. (2020), inactivated vaccinations include destroyed or inactivated versions of the pathogen. Polio and hepatitis A vaccines are examples. Adjuvants may be needed to increase the immune response in these immunizations. Live attenuated vaccines include viruses that can replicate but do not cause life- threatening diseases, according to Haegeman et al. (2002). Live attenuated vaccinations include oral polio and MMR. Although immune-compromised people shouldn't use them, they give long- term protection. Subunit, Recombinant, and Conjugate Vaccines: These vaccines employ solely pathogen proteins or polysaccharides to induce an immune response (Dai et al., 2019). Examples include hepatitis B and HPV vaccinations. Recombinant vaccines employ genetically engineered 5

6 antigens to increase the immune response, whereas conjugate vaccines combine an antigen with a carrier protein. These include pneumococcal and Hib vaccines. mRNA vaccines: mRNA vaccines use a cutting-edge methodology, such as the COVID- 19 vaccines created by Pfizer-BioNTech and Moderna. These vaccines deliver to the body a little fragment of mRNA that encodes the viral spike protein. The mRNA tells cells to create the spike protein once inside, which starts an immunological response. In the fight against COVID-19, mRNA vaccines have shown astounding effectiveness (Verbeke et al., 2021). Additionally, mRNA vaccines have transformed the immunization world and have shown to be very efficient in the fight against COVID-19. The first vaccines approved for use in an emergency, the Pfizer-BioNTech and Moderna COVID-19 vaccines, have substantially contributed to the worldwide immunization drive. Delivering a brief section of messenger RNA (mRNA) into the body is the basic idea behind mRNA vaccines (Barbier et al., 2022). In the case of COVID-19 vaccinations, this mRNA encodes the spike protein that may be detected on the surface of the SARS-CoV-2 virus. These instructions are used to manufacture a particular viral protein. The mRNA acts as a template for the body's cells to create the spike protein after it has been absorbed by the cells. The cells' surface then displays the spike protein that was created within. In reaction, the immune system mounts an immunological response after identifying it as foreign (Verbeke et al., 2021). The immune response involves both the generation of antibodies and the activation of immune cells to neutralize the spike protein. The immune reaction offers a defense against coming into contact with the virus again in the future. There are several benefits to comparing mRNA vaccines to conventional vaccination strategies. First, they are quick to design and generate, which was helpful during the COVID-19 epidemic. A quicker response to newly developing infectious illnesses is possible because of the ability to generate the mRNA 6

Your preview ends here

Eager to read complete document? Join bartleby learn and gain access to the full version

Access to all documents
Unlimited textbook solutions
24/7 expert homework help

7 sequence in the lab using the virus's genetic information (Verbeke et al., 2021). MRNA vaccines may also be easily modified. If a virus develops new variations, the mRNA sequence may be swiftly changed to match the updated spike protein. Due to its adaptability, booster injections or altered vaccination formulations may be created to meet changing virus strains (Barbier et al., 2022). Furthermore, in both clinical studies and actual usage, mRNA vaccines have been shown to have outstanding safety profiles. Most side effects, such as weariness, headaches, or injection site pain, are minor and transient. Extremely seldom are severe adverse effects. mRNA vaccines don't alter DNA. mRNA remains in the cytoplasm, not the cell's nucleus, where DNA resides. As a result, it does not assemble into the vaccine recipient's genetic makeup. 7

8 References Barbier, A. J., Jiang, A. Y., Zhang, P., Wooster, R., & Anderson, D. G. (2022). The clinical progress of mRNA vaccines and immunotherapies. Nature Biotechnology, 40(6), 840- 854. Brisse, M., Vrba, S. M., Kirk, N., Liang, Y., & Ly, H. (2020). Emerging concepts and technologies in vaccine development. Frontiers in immunology, 11, 583077. Dai, X., Xiong, Y., Li, N., & Jian, C. (2019). Vaccine types. In Vaccines-the history and future. IntechOpen. Dubé, È. Ward, J. K., Verger, P., & MacDonald, N. E. (2021). Vaccine hesitancy, acceptance, and anti-vaccination: trends and prospects for public health. Annu Rev Public Health, 42(1), 175-91. Esparza, J. (2020). Early vaccine advocacy: Medals honoring Edward Jenner were issued during the 19th century. Vaccine, 38(6), 1450-1456. Gao, Q., Bao, L., Mao, H., Wang, L., Xu, K., Yang, M., & Qin, C. (2020). Development of an inactivated vaccine candidate for SARS-CoV-2. Science, 369(6499), 77-81. Haegeman, A., De Leeuw, I., Saduakassova, M., Van Campe, W., Aerts, L., Philips, W., ... & De Clercq, K. (2021). The importance of quality control of LSDV live attenuated vaccines for their safe application in the field. Vaccines, 9(9), 1019. Iwasaki, A., & Omer, S. B. (2020). Why and how vaccines work. Cell, 183(2), 290-295. Saleh, A., Qamar, S., Tekin, A., Singh, R., & Kashyap, R. (2021). Vaccine development throughout history. Cureus, 13(7). Verbeke, R., Lentacker, I., De Smedt, S. C., & Dewitte, H. (2021). The dawn of mRNA vaccines: The COVID-19 case. Journal of Controlled Release, 333, 511-520. 8

Research Report on Vaccines.edited.edited

Related Documents